Envoy Medical receives European patent for cochlear implant technology

Envoy Medical, Inc.

European Patent No. 4338791 granted, effective Sept 17, 2025, covering implantable cochlear system with integrated components and lead characterization.
Patent covers methods for compensating variability in middle ear sensor using analog/digital signals and adjustable digital filter.
Follows recent patent issuances in the US, Australia, and Hong Kong, expanding global patent portfolio.
CEO Brent Lucas says patent strengthens position and supports mission for fully implantable hearing solutions.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.